This study investigated the effect of a fully automated dCBT program on insomnia severity, sleep–wake patterns, sleep medication use, and daytime impairment.
Ongoing COVID-19 studies may not be paying attention to the risk factors of insomnia. In this study, the prevalence of insomnia and its contributing factors in a general public sample was documented.
Is there a causal relationship between depressive disorders and late-life neurodegenerative diseases? Or, is their co-occurrence due to confounding or common risk factors, such as aging?
Most wearable devices used by consumers lack requisite validation. Current widespread usage necessitates an examination of their performance.
Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
In order to assess the efficacy and safety of JZP-258, a lower sodium alternative product to sodium oxybate, study authors designed a double-blind, placebo-controlled, randomized withdrawal, multicenter study with an open-label safety extension.
Study findings suggest that mental health during childhood and adolescence was associated with future health behaviors.
In young adults, the use of electronic devices was found to contribute to insomnia symptoms more than mood disturbance, age, and biological sex.
Snoring is associated with increased risk of cerebral events in patients with obstructive sleep apnea and established cardiovascular disease.
Among participants living in a culturally diverse area of Greece, people with anxiety were more likely to experience loss of sleep or other sleep-related disorders.